The second Advanced Biotechnology for Sustainability report translates a $1.1 trillion market opportunity into a concrete action plan, pinpointing four molecule families — terpenes, peptides, non-catalytic proteins, and hydroxy acids — as the fastest routes to industrial-scale biobased production. It provides a prioritization framework to help organizations identify where to invest, collaborate, and scale, and sets out a bold, unified call to move advanced biotechnology from promise to commercial reality.